DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Bureau C, Thabut D, Jezequel C. et al.
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
Ann Intern Med 2021;
174 (05) 633-640
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.